OOIR: Observatory of International Research

Papers

(The TQCC of Heart Failure Clinics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Unusual Forms of Pulmonary Hypertension	66
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure	30
Genetic Risk Stratification in Arrhythmogenic Left Ventricular Cardiomyopathy	28
Tafamidis in the Treatment of ATTR-related Cardiomyopathy	27
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging	25
When all Else Fails, Try This	25
Understanding Myocardial Metabolism in the Context of Cardio-Oncology	23
Changing Landscape of Heart Failure Imaging	21
Forthcoming Issues	21
Contents	20
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia	20
Emerging Targeted Therapies for Inherited Cardiomyopathies and Arrhythmias	19
Therapy-Related Clonal Hematopoiesis	18
Contributors	17
Contributors	17
Genetic Determinants of Response to P2Y12 Inhibitors and Clinical Implications	17
Genetics of High-Altitude Pulmonary Edema	16
Pharmacologic and Lifestyle Interventions to Modulate the Epigenome in Heart Failure	16
Mitral Regurgitation	15
Heart Failure in Adults with Congenital Heart Disease: The Time to Act is Now	14
Rare Cardiovascular Diseases: From Genetics to Personalized Medicine	14
Contributors	13
Preload Reduction Therapies in Heart Failure	13
Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options for Heart Failure with Reduced Ejection Fraction	13
Arrhythmias in Adult Congenital Heart Disease Heart Failure	13

The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis	12
Contributors	12
Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure	12
What Is New in Risk Assessment in Nuclear Cardiology?	12
Redefining Left Ventricular Systolic Dysfunction in Hypertrophic Cardiomyopathy	12
Copyright	11
Specific Therapy in Transthyretin Amyloid Cardiomyopathy	11
Heart Failure Clinics	11
Emerging Roles for Artificial Intelligence in Heart Failure Imaging	10
Arrythmia-Mediated Valvular Heart Disease	10
Myocardial Dysfunction in Patients with Cancer	10
Coronary Angiography in the Evaluation of Systolic Heart Failure	9
Shifting the Epigenetic and Multi-Omic Frontier to Get the Heart in Top Gear	9
Special Considerations for Mechanical Circulatory Support or Device Therapy in Adult Congenital Heart Disease Heart Failure	9
SGLT2 Inhibitors in Heart Failure	9
Obtaining a Coronary Artery Calcium Score with Myocardial Perfusion Imaging	9
Guide to Temporary Mechanical Support in Cardiogenic Shock	9
Cardiac Amyloidosis	9
Application of 3D Printing Technology in Heart Failure	8
Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging	8
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population	8
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis	8
Noncoding RNAs in Pulmonary Arterial Hypertension	7
The Role of Multimodality Imaging in the Evaluation of Heart Failure and Surgical Transplant Planning of Patients with Adult Congenital Heart Disease	7
Cardiac Contractility Modulation	7
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors	6
Epigenetics of Heart Failure	6
Radionuclide Tracers for Myocardial Perfusion Imaging and Blood Flow Quantification	6
SGLT2 Inhibitors in Type 2 Diabetes Mellitus	6
Contents	6
Contributors	6
Copyright	6
Contents	6
Preface	6
Contents	6
The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes	6
Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study	6
Contents	5
Contents	5
Copyright	5
Exercise Testing in Pulmonary Hypertension and Heart Failure	5
Adults with Congenital Heart Disease and Transplant	5
Aortic Valvular Stenosis and Heart Failure	5
The Role of Medical Therapy in Hypertrophic Cardiomyopathy	4
Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy	4
Clinical Practice Guidelines in Cardio-Oncology	4
SGLT2 Inhibitors and Peripheral Vascular Events	4
Remote Monitoring Devices and Heart Failure	4
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure	4
The Risk of Sudden Unexpected Cardiac Death in Children	3

Advances in the Therapy of Light Chain Cardiac Amyloidosis	3
Forthcoming Issues	3
Clinical Value of Positron Emission Tomography Myocardial Perfusion Imaging and Blood Flow Quantification	3
Clinical Use of Biomarkers in Cardiac Amyloidosis	3
Risk Factors for Progression in Hypertrophic Cardiomyopathy	3
Contributors	3
Forthcoming Issues	3
Contributors	3
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease	3
Coronary Microvascular Dysfunction	3
Novel Non-pharmacological Approaches to Heart Failure	3
Pathophysiology of Cardiac Amyloidosis	3
Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?	3
Contributors	3